Medicenna Therapeutics Corp's total assets for Q1 2025 were C$38.02M, an increase of 98.73% from the previous quarter. MDNAF total liabilities were C$15.14M for the fiscal quarter, a 8.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.